• Tülin Kuyucu, Salih Zeki Güçlü, Bengü Saylan, Cahit Demir, Tuncer Senol, Serdar Güner, Ejder Koyuncu, Ferit Ozen, Sezai Oztürk, Zeki Cangül, Semih Ağanoğlu, Sevket Ozkaya, Sevilay Ciçek Ocak, Hüseyin Akkurt, Yavuz Selim Intepe, Merve Gülcan Bayrak, Tuncay Güler, Taha Tahir Bekçi, Sadan Soyyiğit, Salim Seyfettin, Ozhan Kula, Makbule Ozlem Akbay, Bengü Büyükgöze, Gökhan Asal, Seyma Başlilar, Osman Oztürk, and Turkey SUNRISE Study Group.
• Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey. tnkuyucu@yahoo.com
• Tuberk Toraks. 2011 Jan 1;59(4):328-39.

AbstractChronic obstructive pulmonary disease (COPD) is a lung disease characterized with limitation of airflow that is not completely reversible, progressive deterioration of airways and systemic inflammation. This study has been planned to determine daily symptom variability of patients, expectations of patient and physicians from treatment and patient profiles. A total of 514 patients with COPD from 25 centers were included in this national, multicenter, cross-sectional observational study. Data regarding demographic features, concomitant diseases, history and treatment of COPD and expectations of patients and physicians were all obtained in a single visit. Mean [standard deviation (SD)] age of the patients was 64.1 (9.5) years; age range was 41-92 years, 50% of the patients were younger than 65 years and 91% were males. Educational level of the patients was at least primary school in 80.2%; and 54.3% (30.4%) of the patients had at least one concomitant disease, particularly a cardiovascular disease. Mean (SD) duration of having COPD was 5.4 (4.6) years. The majority of patients were at moderate (43.2%) and severe (35.0%) COPD stages and one or more exacerbations per year was determined in 71%. Inhaled beta-2 agonists (84.2%), inhaled steroids (76.3%) and inhaled long-acting anti-cholinergics (70.0%) were the most commonly used medications. Dyspnea (99.0%), sputum production (92.8%) and wheezing (90.5%) were the most common symptoms, and symptom variability for dyspnea (41.1%), sputum production (61.0%) and cough (53.5%) were seen the most in the morning hours (p< 0.001). Most commonly affected morning activity was climbing up/down the stairs (point of effect: 6.7), followed by wearing socks/shoes (point of effect: 4.3) and showering/bathing (point of effect: 4.2) by COPD. Major treatment expectations of patients were greater symptomatic relief (82.3%) and greater mobility (70.0%), faster symptomatic relief (61.1%) and improvement in morning activities (59.3%); while major treatment expectations of physicians included increased quality of life (100.0%) and decreased morbidity (96.0%). Quitting smoking was the most commonly recommended (88.3%) and implemented (67.9%) non-drug protective approach aimed at decreasing the frequency of exacerbations. Consequently, our results demonstrate that COPD is not a disease of only the elderly, is an important healthcare issue that often disrupt daily living of the patients due to inadequate disease awareness leading to overlooking of the symptoms by patient and physicians, and that a patient-centered approach based on the living standards, life expectancies and preferences of patients was crucial in patient management.

28 keywords...

hide…